title: Protective effects of inhaled ipratropium bromide on bronchoconstriction induced by adenosine and methacholine in asthma.
abstract: Although adenosine-induced bronchoconstriction is mainly due to mast cell mediator release, vagal reflexes have also been implicated in this response. We have investigated the effect of a specific muscarinic-receptor antagonist, ipratropium bromide, on methacholine- and adenosine-induced bronchoconstriction in a randomized, placebo-controlled, double-blind study of 12 asthmatic subjects. Airway response was evaluated as forced expiratory volume in one second (FEV1). Inhaled ipratropium bromide (40 micrograms), administered 20 min prior to bronchoprovocation, increased the provocation dose of inhaled methacholine and adenosine required to reduce FEV1 by 20% from baseline (PD20) from 0.11 to 0.79 mg (p less than 0.01) and from 0.57 to 1.27 mg (p less than 0.01), respectively. The mean baseline FEV1 values after administration of ipratropium bromide were significantly higher than after placebo administration (p less than 0.05). However, there was no correlation between the degree of bronchodilatation and dose-ratios for methacholine and adenosine. The findings of the present study implicate vagal reflexes in the bronchospastic response induced by inhaled adenosine in asthma.
authors.affiliation: Istituto di Malattie dell'Apparato Respiratorio e Tisiologia, Universita' di Catania, Italy.
authors.forename: N
authors.initials: N
authors.lastname: Crimi
authors.forename: F
authors.initials: F
authors.lastname: Palermo
authors.forename: R
authors.initials: R
authors.lastname: Oliveri
authors.forename: R
authors.initials: R
authors.lastname: Polosa
authors.forename: I
authors.initials: I
authors.lastname: Settinieri
authors.forename: A
authors.initials: A
authors.lastname: Mistretta
mesh_terms: D000241:Adenosine / Q000008:administration & dosage; D000280:Administration, Inhalation; D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000503:physiopathology*; D016084:Bronchoconstriction / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D016210:Methacholine Chloride / Q000008:administration & dosage; D008875:Middle Aged; D012018:Reflex / Q000502:physiology; D014630:Vagus Nerve / Q000503:physiopathology
chemical_list: D016210:Methacholine Chloride; D009241:Ipratropium; D000241:Adenosine